Corbion Q1 2014 Interim Management StatementCorbion reported positive net sales and EBITDA growth in Q1 2014 despite significant negative exchange rate effects. Organic sales growth was 3.0% due to strong growth in the Biochemicals segment. EBITDA before one-off costs at constant currencies increased by € 3.2 million or 13.6% compared to Q1 2013. Expenditure on R&D rose significantly.
Product not available in your region
This product is not available in the selected region.
If you want this product in your region, or find a suitable alternative, please contact us,